Affimed
Affimed is a Germany-based biotechnology company that develops and commercializes antibody therapeutics for the treatment of cancer.
Business Model:
Revenue: $45.8M
Employees: 51-200
Industries / Tags:
Detailed Affimed Information
Geographic Data
Address: Technologiepark
City: Heidelberg
State: baden-württemberg
Zip: 69120
Country: DE
Financial Info
Stage:
post ipo equity
Raised Last:
$90M
Raised Total:$521M
Social
Metrics
3,292,146Website Global Rank
4,620Website Monthly Traffic
Twitter Followers
Description
Affimed is a Germany-based biotechnology company that develops and commercializes antibody therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Affimed went public on 9/12/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/12/2014
Ticker Symbol:
AFMD
IPO Price:
$7/share
Amount Raised:
$56M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
